Ensayo clínico multicéntrico, aleatorizado, doble ciego, en fase II y en dos etapas para evaluar la eficacia y la seguridad de MK-0594 en pacientes con alcoholismo. A Phase II Multicenter, Randomized, Double-Blind, Two-Stage Clinical Trial to Evaluate the Efficacy and Safety of MK-0594 in Patients with Alcohol Dependence

Registry ID

EUCTR2008-004686-26

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Merck & Co., Inc.

Start date

2009-07-29

Completion date

2010-03-11

Last update

2026-08-16

Conditions

• Alcohol Dependence
• Dependencia Alcohólica Alcohol Dependence

Summary

Evaluate efficacy of MK-0594 in maintaining absence of heavy alcohol drinking over Weeks 3-12 of a 12-week treatment period

Locations

• , , Germany
• , , Spain
• , , Belgium
• , , France

Related clinical trials

• Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
• Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)
• Behavioral and Functional Task Development, Implementation, and Testing
• Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence
• Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study
• Effects of Ketone Supplementation on Acute Alcohol Withdrawal

View on source registry